ATP5F1A and prostate carcinoma: In addition, phosphorylation of ATP5F1A at Y243/246 can maintain high mitochondrial output, and this mechanism is activated in prostate cancer [40], suggesting that posttranslational modification of ATP5F1A has a potentially powerful regulatory role in diseases.